Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)
Clinical trial NCT02175355 · COMPLETED
Trial details
- NCT number
- NCT02175355
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-10-01
- Primary completion
- 2000-08-01
- Enrollment
- 1039
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.